Allegro Ophthalmics to Present the Results of ALG-1007 Ex-U.S. Phase 2 Clinical Trial for Dry Eye Disease at the 2021 ASCRS ASOA Annual Meeting

SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)-- #AllegroEye--Allegro Ophthalmics to present the results of ALG-1007 ex-U.S. Phase 2 clinical trial for dry eye disease at the 2021 ASCRS ASOA Annual Meeting.

Click to view original post